glp-1 agonist mechanism Glucagon-like peptide-1 Frontiers | Mechanisms of action
Description
No dependence on remaining beta cell function
In the next section, we will discuss this complex interplay (Fig
As hinted above, this predicament could be disentangled via studies that include a mechanistic assessment of biomarkers predicting response versus harm following GLP-1RA administration 192
In practice, however, many patients are prescribed the drug with little additional support, and a significant number stop treatment early
